Td Capital Management LLC Amgen Inc Transaction History

Td Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $6,721 - $8,114	25 New	25 $7,000
Q2 2023 Aug 16, 2023	SELL	$214.27 - $253.37 $5,999 - $7,094	-28 Reduced 87.5%	4 $0
Q4 2022 Feb 15, 2023	BUY	$229.03 - $291.01 $6,412 - $8,148	28 Added 700.0%	32 $8,000
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $897 - $1,012	4 New	4 $1,000
Q1 2022 May 18, 2022	SELL	$219.27 - $242.57 $877 - $970	-4 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $887 - $1,034	4 New	4 $1,000

3,054

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Td Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Td Capital Management LLC with notifications on news.